RGNX Award Disclosure
Chan Mitchell · SEC Form 4 · Filed Nov 3, 2026
Award
Calculated transaction value
$0
Chan Mitchell Chief Financial Officer
RGNX
REGENXBIO Inc
RGNX
Transaction date
Nov 1, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 2 days later
RGNX daily price context
Close on/before transaction
$7.2
Oct 30, 2026
First close after public filing
$7.71
Nov 4, 2026
Return after filing · so far
-1.17%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 24,305 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001789335-26-000010
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Regenxbio Inc. RGNX Current | Award | Nov 1, 2026 | $0 |